WHWK

insider transactions

Whitehawk Therapeutics, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 90d

-695.8K

0 buy · 695.8K sell

Net value · 90d

-$2.6M

$0 in · $2.6M out

Sentiment · 90d

Net selling

0% buying · 100% selling

Open-market trades · 90d

0 buy · 695.8K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 12, 26

Baiteng Zhao

Director

$0

38.0K sh

Own New
Grant·A
Jun 12, 26

Emma Reeve

Director

$0

38.0K sh

Own New
Grant·A
Jun 12, 26

Richard E Maroun

Director

$0

38.0K sh

Own New
Grant·A
Jun 12, 26

Mohammad Hirmand

Director

$0

38.0K sh

Own New
Grant·A
Jun 12, 26

Neil Desai

Director

$0

38.0K sh

Own New
Grant·A
Jun 12, 26

Caley Castelein

Director

$0

38.0K sh

Own New
Grant·A
Jun 12, 26

Behzad Aghazadeh / Avoro Capital Advisors LLC / Avoro Ventures LLC

Director, 10% Owner

$0

38.0K sh

Own New
Grant·A
May 14, 26

David James Lennon KEY

CHIEF EXECUTIVE OFFICER

$200.0K

51.0K sh · $3.92

Own +10%
Grant·A
May 14, 26

Scott M. Giacobello KEY

CHIEF FINANCIAL OFFICER

$150.0K

38.3K sh · $3.92

Own +13%
Grant·A
May 14, 26

Margaret Dugan

Chief Medical Officer

$75.0K

19.1K sh · $3.92

Own New
Grant·A
May 14, 26

Caley Castelein

Director

$16841.1B

2.1M sh · $8,124,996.24

Own New
Grant·A
May 14, 26

Caley Castelein

Director

$1000.0K

255.1K sh · $3.92

Own +1295%
Grant·A
May 14, 26

Bryan Ball

Chief Technical Operations Of…

$200.0K

51.0K sh · $3.92

Own +13%
Grant·A
May 12, 26

Avoro Capital Advisors LLC / Behzad Aghazadeh / Avoro Ventures LLC

Director, 10% Owner

$25.0M

6.4M sh · $3.92

Own +77%
Sell·S
Apr 16, 26

Scott M. Giacobello KEY

CHIEF FINANCIAL OFFICER

$584.8K

141.6K sh · $4.13

Own -32%
Sell·S
Apr 15, 26

Scott M. Giacobello KEY

CHIEF FINANCIAL OFFICER

$297.2K

77.0K sh · $3.86

Own -15%
Sell·S
Apr 14, 26

Bryan Ball

Chief Technical Operations Of…

$336.6K

92.5K sh · $3.64

Own -19%
Sell·S
Apr 13, 26

Bryan Ball

Chief Technical Operations Of…

$91.3K

26.4K sh · $3.46

Own -5%
Sell·S
Apr 10, 26

Bryan Ball

Chief Technical Operations Of…

$22.6K

6.6K sh · $3.43

Own -1%
Sell·S
Apr 9, 26

David James Lennon KEY

CHIEF EXECUTIVE OFFICER

$49.0K

14.5K sh · $3.38

Own -3%
Sell·S
Apr 9, 26

Bryan Ball

Chief Technical Operations Of…

$178.5K

50.0K sh · $3.57

Own -9%
Sell·S
Apr 8, 26

David James Lennon KEY

CHIEF EXECUTIVE OFFICER

$217.4K

63.9K sh · $3.40

Own -11%
Sell·S
Apr 7, 26

David James Lennon KEY

CHIEF EXECUTIVE OFFICER

$322.7K

94.1K sh · $3.43

Own -14%
Sell·S
Apr 6, 26

David James Lennon KEY

CHIEF EXECUTIVE OFFICER

$359.4K

102.4K sh · $3.51

Own -13%
Sell·S
Apr 2, 26

David James Lennon KEY

CHIEF EXECUTIVE OFFICER

$93.5K

26.9K sh · $3.48

Own -3%
Grant·A
Apr 1, 26

David James Lennon KEY

CHIEF EXECUTIVE OFFICER

$0

831.1K sh

Own New
Exercise·M
Apr 1, 26

David James Lennon KEY

CHIEF EXECUTIVE OFFICER

$0

775.8K sh

Own New
Exercise·M
Apr 1, 26

David James Lennon KEY

CHIEF EXECUTIVE OFFICER

—

775.8K sh

Own +1740%
Grant·A
Apr 1, 26

Scott M. Giacobello KEY

CHIEF FINANCIAL OFFICER

$0

300.7K sh

Own New
Exercise·M
Apr 1, 26

Scott M. Giacobello KEY

CHIEF FINANCIAL OFFICER

$0

473.9K sh

Own New
Exercise·M
Apr 1, 26

Scott M. Giacobello KEY

CHIEF FINANCIAL OFFICER

—

473.9K sh

Own +1686%
Grant·A
Apr 1, 26

Margaret Dugan

Chief Medical Officer

$0

283.2K sh

Own New
Grant·A
Apr 1, 26

David Dornan

Chief Scientific Officer

$0

282.3K sh

Own New
Grant·A
Apr 1, 26

Bryan Ball

Chief Technical Operations Of…

$0

250.1K sh

Own New
Exercise·M
Apr 1, 26

Bryan Ball

Chief Technical Operations Of…

$0

366.5K sh

Own New
Exercise·M
Apr 1, 26

Bryan Ball

Chief Technical Operations Of…

—

366.5K sh

Own +178%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 12, 2026	Baiteng Zhao	Director	Grant A	38.0K	New	—	$0
Jun 12, 2026	Emma Reeve	Director	Grant A	38.0K	New	—	$0
Jun 12, 2026	Richard E Maroun	Director	Grant A	38.0K	New	—	$0
Jun 12, 2026	Mohammad Hirmand	Director	Grant A	38.0K	New	—	$0
Jun 12, 2026	Neil Desai	Director	Grant A	38.0K	New	—	$0
Jun 12, 2026	Caley Castelein	Director	Grant A	38.0K	New	—	$0
Jun 12, 2026	Behzad Aghazadeh / Avoro Capital Advisors LLC / Avoro Ventures LLC	Director, 10% Owner	Grant A	38.0K	New	—	$0
May 14, 2026	David James Lennon KEY	CHIEF EXECUTIVE OFFICER	Grant A	51.0K	+10%	$3.92	$200.0K
May 14, 2026	Scott M. Giacobello KEY	CHIEF FINANCIAL OFFICER	Grant A	38.3K	+13%	$3.92	$150.0K
May 14, 2026	Margaret Dugan	Chief Medical Officer	Grant A	19.1K	New	$3.92	$75.0K
May 14, 2026	Caley Castelein	Director	Grant A	2.1M	New	$8,124,996.24	$16841.1B
May 14, 2026	Caley Castelein	Director	Grant A	255.1K	+1295%	$3.92	$1000.0K
May 14, 2026	Bryan Ball	Chief Technical Operations Officer	Grant A	51.0K	+13%	$3.92	$200.0K
May 12, 2026	Avoro Capital Advisors LLC / Behzad Aghazadeh / Avoro Ventures LLC	Director, 10% Owner	Grant A	6.4M	+77%	$3.92	$25.0M
Apr 16, 2026	Scott M. Giacobello KEY	CHIEF FINANCIAL OFFICER	Sell S	141.6K	-32%	$4.13	$584.8K
Apr 15, 2026	Scott M. Giacobello KEY	CHIEF FINANCIAL OFFICER	Sell S	77.0K	-15%	$3.86	$297.2K
Apr 14, 2026	Bryan Ball	Chief Technical Operations Officer and SVP, Manufacturing Operations	Sell S	92.5K	-19%	$3.64	$336.6K
Apr 13, 2026	Bryan Ball	Chief Technical Operations Officer and SVP, Manufacturing Operations	Sell S	26.4K	-5%	$3.46	$91.3K
Apr 10, 2026	Bryan Ball	Chief Technical Operations Officer and SVP, Manufacturing Operations	Sell S	6.6K	-1%	$3.43	$22.6K
Apr 9, 2026	David James Lennon KEY	CHIEF EXECUTIVE OFFICER	Sell S	14.5K	-3%	$3.38	$49.0K
Apr 9, 2026	Bryan Ball	Chief Technical Operations Officer and SVP, Manufacturing Operations	Sell S	50.0K	-9%	$3.57	$178.5K
Apr 8, 2026	David James Lennon KEY	CHIEF EXECUTIVE OFFICER	Sell S	63.9K	-11%	$3.40	$217.4K
Apr 7, 2026	David James Lennon KEY	CHIEF EXECUTIVE OFFICER	Sell S	94.1K	-14%	$3.43	$322.7K
Apr 6, 2026	David James Lennon KEY	CHIEF EXECUTIVE OFFICER	Sell S	102.4K	-13%	$3.51	$359.4K
Apr 2, 2026	David James Lennon KEY	CHIEF EXECUTIVE OFFICER	Sell S	26.9K	-3%	$3.48	$93.5K
Apr 1, 2026	David James Lennon KEY	CHIEF EXECUTIVE OFFICER	Grant A	831.1K	New	—	$0
Apr 1, 2026	David James Lennon KEY	CHIEF EXECUTIVE OFFICER	Exercise M	775.8K	New	—	$0
Apr 1, 2026	David James Lennon KEY	CHIEF EXECUTIVE OFFICER	Exercise M	775.8K	+1740%	—	—
Apr 1, 2026	Scott M. Giacobello KEY	CHIEF FINANCIAL OFFICER	Grant A	300.7K	New	—	$0
Apr 1, 2026	Scott M. Giacobello KEY	CHIEF FINANCIAL OFFICER	Exercise M	473.9K	New	—	$0
Apr 1, 2026	Scott M. Giacobello KEY	CHIEF FINANCIAL OFFICER	Exercise M	473.9K	+1686%	—	—
Apr 1, 2026	Margaret Dugan	Chief Medical Officer	Grant A	283.2K	New	—	$0
Apr 1, 2026	David Dornan	Chief Scientific Officer	Grant A	282.3K	New	—	$0
Apr 1, 2026	Bryan Ball	Chief Technical Operations Officer and SVP, Manufacturing Operations	Grant A	250.1K	New	—	$0
Apr 1, 2026	Bryan Ball	Chief Technical Operations Officer and SVP, Manufacturing Operations	Exercise M	366.5K	New	—	$0
Apr 1, 2026	Bryan Ball	Chief Technical Operations Officer and SVP, Manufacturing Operations	Exercise M	366.5K	+178%	—	—

About WHWK insider trading

This page tracks insider transactions for Whitehawk Therapeutics, Inc. (WHWK) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.